In this study, bioinformatics analysis and experimental validation confirmed the down-regulation of CXCL2 in HCC, and overexpression of CXCL2 increased intracellular ROS, Fe2+ and MDA levels. This evidence concerns the gene CXCL2 and hepatocellular carcinoma.